Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

national-cancer-institute-l8twzt4ccvq-unsplash_1

Swing Therapeutics receives FDA authorisation for digital therapeutic for fibromyalgia

May 22, 2023 Medical Communications CBT, Devices, FDA, Swing Therapeutics, fibromyalgia

Swing Therapeutics has announced that it has received De Novo marketing authorisation from the US Food and Drug Administration for …
News
brano-mm1vipqd0oa-unsplash

Krystal Biotech secures FDA approval for redosable topical gene therapy

May 22, 2023 Medical Communications FDA, Krystal Biotech, Paediatrics, dystrophic epidermolysis bullosa, gene therapy

US-based biotech company Krystal Biotech has announced that the US Food and Drug Administration (FDA) has approved its topical gene …
News

Schott Pharma announces pre-filled polymer syringes for deep-cold medication

May 19, 2023 Medical Communications Devices, Schott Pharma, deep cold medication, syringe

Germany-based drug delivery solutions company Schott Pharma has announced its pre-fillable syringes (PFS) for drugs requiring deep-cold, such as those …
News
milad-fakurian-58z17lnvs4u-unsplash_2

NHS given guidance on offering genetic testing to stroke patients

May 19, 2023 Medical Communications NHS, Neurology, blood clot, genetic testing, stroke

The NHS has been given draft guidance on offering gene tests to patients who have had a stroke caused by …
News

NICE recommends Kapruvia for treatment of moderate-to-severe CKD-associated pruritus

May 18, 2023 Medical Communications Kapruvia, NICE, Nephrology, chronic kidney disease, pruritus

Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Cara Therapeutics have announced that the National Institute for Health and Care …
News

US appeals court hears arguments in abortion pill case

May 18, 2023 Medical Communications Obstetrics & Gynaecology, abortion, medication abortion, mifepristone, reproduction

The ongoing court battle surrounding the contested approval of mifepristone, one of the drugs used in medication abortions, has now …
News

NICE recommends nine digital treatment options for depression and anxiety

May 17, 2023 Medical Communications NICE, Neurology, anxiety, depression, digital health, mental health

The National Institute for Health and Care Excellence (NICE) has recommended six digitally enabled therapies for adult patients with anxiety …
News

RadioMedix and Orano Med complete patient enrolment for neuroendocrine cancer trial

May 16, 2023 Medical Communications Oncology, Orano Med, RadioMedix, neuroendocrine cancer, oncology

US-based RadioMedix and French Orano Med, two clinical stage radiopharmaceutical companies, have announced that the last patient has been enrolled …
News

NICE recommends Hepcludex for NHS use to treat aggressive form of viral hepatitis

May 15, 2023 Medical Communications NHS, NICE, Virology, hepatitis

The National Institute for Health and Care Excellence (NICE) has recommended Hepcludex (bulevirtide) for the treatment of chronic hepatitis delta …
News
hal-gatewood-_jbclosdsd4-unsplash

FDA approves new nonhormonal medication for menopause hot flashes

May 15, 2023 Medical Communications FDA, HRT, Veozah, hot flashes, menopause

The US Food and Drug Administration (FDA) has announced its approval of Veozah (fezolinetant), an oral medication to treat moderate …
News

FDA relaxes blood donation regulations for MSM

May 12, 2023 Medical Communications FDA, HIV, HIV/AIDS, blood donation

The US Food and Drug Administration (FDA) has released updated guidance for blood donation which relaxes the rules for donations …
News

Bellerophon Therapeutics completes phase 3 study for fibrotic interstitial lung disease drug

May 12, 2023 Medical Communications Bellerophon Therapeutics, Cardiology, clinical trial, lung disease

US clinical stage biotherapeutics company Bellerophon Therapeutics has announced that the last patient has completed its phase 3 REBUILD study, …
News

FDA advisory committee votes in favour of OTC contraceptive pill

May 11, 2023 Medical Communications Contraception, FDA, OTC, Perrigo, contraception

Perrigo Company has announced that the US Food and Drug Administration’s (FDA) Nonprescription Drugs Advisory Committee (NDAC) and the Obstetrics, …
News

Otsuka and Lundbeck gain FDA approval for supplemental New Drug Application for dementia drug

May 11, 2023 Medical Communications FDA, Lundbeck, Neurology, Otsuka Pharmaceuticals, alzheimer's disease, dementia

Japan-based healthcare company Otsuka Pharmaceutical and Danish pharma company Lundbeck have announced that the US Food and Drug Administration (FDA) …
News

AstraZeneca’s Ultomiris approved in EU for adults firm NMOSD

May 11, 2023 Medical Communications AstraZeneca, NMOSD, Neurology, Ultomiris, neurology

AstraZeneca has announced the approval of Ultomiris (ravulizumab) in the European Union (EU) for the treatment of adult patients with …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025